Wednesday, December 09, 2020

#AIEye #Podcast 492: AWS (NasdaqGS: $AMZN) Announces New ML Capabilities for SageMaker and IBM (NYSE: $IBM) Announces New #AI, NLP Capabilities for Watson #artificialintelligence

#AIEye #Podcast 492: AWS (NasdaqGS: $AMZN) Announces New ML Capabilities for SageMaker and IBM (NYSE: $IBM) Announces New #AI, NLP Capabilities for Watson #artificialintelligence


Global AI in Drug Discovery Market to Decline to $360 Million in 2020 Due to COVID-19, but Reach $1.1 Billion by 2023


Point Roberts WA, Vancouver BC – December 9, 2020  – (, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence


Listen to today’s podcast:


Read this in full at


Hear the Ai Eye on Spotify  


Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence


Stocks discussed: (NasdaqGS: AMZN) (NYSE:IBM)


Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced nine new capabilities for its machine learning service Amazon SageMaker. According to the press release, these capabilities include: “faster data preparation, a purpose-built repository for prepared data, workflow automation, greater transparency into training data to mitigate bias and explain predictions, distributed training capabilities to train large models up to two times faster, and model monitoring on edge devices.” Swami Sivasubramanian, Vice President, Amazon Machine Learning, AWS, said:


"Today, we are announcing a set of tools for Amazon SageMaker that makes it much easier for developers to build end-to-end machine learning pipelines to prepare, build, train, explain, inspect, monitor, debug, and run custom machine learning models with greater visibility, explainability, and automation at scale."


IBM (NYSE:IBM) has announced innovative new capabilities for IBM Watson aimed at helping to scale the use of AI by businesses. These capabilities leverage AI and natural language processing (NLP), and include Reading Comprehension, FAQ Extraction, a new intent classification model, and expanded language support from IBM Watson Discovery. Daniel Hernandez, General Manager of Data and AI, IBM, said:


"This past year has shown us that the real power of AI is in helping companies take action and respond to changing conditions in real time. That means in minutes and hours -- not weeks or months. Today's new AI capabilities are yet another example of how cutting-edge AI advancements coming out of IBM Research help us to deliver innovations for language, automation and building trust in IBM Watson that are changing the game for businesses of all sizes and across all industries."


Global AI in Drug Discovery Market to Decline to $360 Million in 2020 Due to COVID-19, but Reach $1.1 Billion by 2023


Research published by ReportLinker finds that the global market for AI in Drug Discovery

is expected to decline from $370 million in 2019 to $360 million in 2020 with a compound annual growth rate (CAGR) of -1.33 percent. This is attributed mainly to the COVID-19 pandemic and its associated “restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges.” However, following this disruptive year, the report indicates that “the market is then expected to recover and reach $1.1 billion in 2023 at a CAGR of 42.9%.”


Sam Mowers,


Read and hear other editions of the AI  Eye


For a list of artificial intelligence stocks on visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The podcasts are also available on iTunes,  Spotify, Tunein, Stitcher,, iHeartRadio and Google Play Music.


Visit the Podcast page at


Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and  Global investors must adhere to regulations of each country. Please read privacy policy:


The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of


Follow us on Twitter

Follow us on Facebook

Follow us on YouTube

Download our Mobile App for iPhone and Android 

Join our Investor Club



800 665 0411


Get more Technology stock investor ideas - news, articles, podcasts and stock directories













































No comments: